These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2982002)

  • 41. Identification of bladder carcinogens by paper chromatography.
    Laham S; Farant JP; Potvin M
    IMS Ind Med Surg; 1970 Mar; 39(3):142-7. PubMed ID: 5265725
    [No Abstract]   [Full Text] [Related]  

  • 42. Risk for bladder cancer. Psychological impact of notification.
    Hornsby JL; Sappington JT; Mongan P; Gullen WH; Bono SF; Altekruse E
    JAMA; 1985 Apr; 253(13):1899-902. PubMed ID: 3974078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experience of tumors in a British plant handling 3 3' dichlorobenzidine.
    MacIntyre DI
    J Occup Med; 1975 Jan; 17(1):23-6. PubMed ID: 1123675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphocyte reactivity of workers exposed to carcinogenic and non-carcinogenic chemicals.
    Kumar S; Taylor G; Hurst W; Wilson P; Costello CB
    Br J Ind Med; 1981 May; 38(2):167-9. PubMed ID: 7236542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Notification of workers about an excess of malignant melanoma: a case study.
    Mazzuckelli LF; Schulte PA
    Am J Ind Med; 1993 Jan; 23(1):85-91. PubMed ID: 8422064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk assessment of a cohort exposed to aromatic amines. Initial results.
    Schulte PA; Ringen K; Hemstreet GP; Altekruse EB; Gullen WH; Patton MG; Allsbrook WC; Crosby JH; West SS; Witherington R
    J Occup Med; 1985 Feb; 27(2):115-21. PubMed ID: 3884754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal management of asymptomatic workers at high risk of bladder cancer.
    Schulte PA; Ringen K; Hemstreet GP
    J Occup Med; 1986 Jan; 28(1):13-7. PubMed ID: 3950777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer risk notification: psychosocial and ethical implications.
    Lerman C; Rimer BK; Engstrom PF
    J Clin Oncol; 1991 Jul; 9(7):1275-82. PubMed ID: 2045867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interventions in high-risk occupational cohorts: a cross-sectional demonstration project.
    Tillett S; Ringen K; Schulte P; McDougall V; Miller K; Samuels S
    J Occup Med; 1986 Aug; 28(8):719-27. PubMed ID: 3746497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevalence of screening in industry: report from the National Institute for Occupational Safety and Health National Occupational Hazard Survey.
    Ratcliffe JM; Halperin WE; Frazier TM; Sundin DS; Delaney L; Hornung RW
    J Occup Med; 1986 Oct; 28(10):906-12. PubMed ID: 3021937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening workers exposed to suspect bladder carcinogens.
    Cartwright RA
    J Occup Med; 1986 Oct; 28(10):1017-9. PubMed ID: 3772536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bladder cancer screening study initiated by Fox Chase.
    Oncology (Williston Park); 1990 Jan; 4(1):16. PubMed ID: 2144178
    [No Abstract]   [Full Text] [Related]  

  • 53. High-risk notification of chromate and bichromate production workers.
    Rosenman KD; Stanbury M; Lemon A; Solice-Sample G; Kalush A
    Am J Ind Med; 1993 Jan; 23(1):125-34. PubMed ID: 8422042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The case for worker notification.
    Ringen K
    Ann N Y Acad Sci; 1989; 572():133-41; discussion 142-3. PubMed ID: 2627071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic importance of specific immunoreactivity in occupational bladder cancer.
    Kumar S; Taylor G; Wilson P; Hurst W
    Br Med J; 1980 Feb; 280(6213):512-3. PubMed ID: 7370564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Economics of notification and medical screening for high-risk workers.
    Ruttenberg R; Powers M
    J Occup Med; 1986 Aug; 28(8):757-64. PubMed ID: 3091789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Occupational bladder cancer: a guide for clinicians. The BAUS Subcommittee on Industrial Bladder Cancer.
    Br J Urol; 1988 Mar; 61(3):183-91. PubMed ID: 3359119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for bladder cancer in high-risk groups: delineation of the problem.
    Schulte PA
    J Occup Med; 1990 Sep; 32(9):789-92. PubMed ID: 2074499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PREVENTION OF OCCUPATIONAL CANCER OF THE URINARY BLADDER IN WORKERS IN ANILINE DYES INDUSTRY IN THE U.S.S.R.
    LIPKIN IL
    Acta Unio Int Contra Cancrum; 1963; 19():467-8. PubMed ID: 14050582
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of medical screening in the prevention of occupational disease.
    Baker EL
    J Occup Med; 1990 Sep; 32(9):787-8. PubMed ID: 2074498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.